End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42,100 KRW | -4.54% | +6.58% | +266.09% |
2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Equipment
99.4
%
| 12,034 | 99.3 % | 13,029 | 99.4 % | +8.27% |
Stem Cell Therapy
2.2
%
| 361 | 3.0 % | 291 | 2.2 % | -19.46% |
Consolidated Adjustment
-1.6
%
| -283 | -2.3 % | -212 | -1.6 % | -25.06% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Foreign
85.6
%
| 10,386 | 85.7 % | 11,216 | 85.6 % | +7.99% |
South Korea
14.4
%
| 1,727 | 14.3 % | 1,892 | 14.4 % | +9.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 29/18/29 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 31/19/31 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/19/29 |
Won-Geun Kim
AUD | Comptroller/Controller/Auditor | 71 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 29/18/29 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 31/19/31 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/19/29 |
Sang-Heon Kim
BRD | Director/Board Member | 57 | 30/18/30 |
Jung-Soon Jang
BRD | Director/Board Member | 67 | 29/19/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,427,076 | 8,023,629 ( 70.22 %) | 0 | 70.22 % |
Company contact information
S.Biomedics Co., Ltd.
4F, Wooil Venture Town Building 28, Seongsui-ro 26-gil
04797, Seoul
+
http://www.sbiomedics.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+266.09% | 35Cr | |
+0.85% | 9.24TCr | |
-3.03% | 3.79TCr | |
-10.46% | 3.37TCr | |
+74.71% | 2.8TCr | |
-13.39% | 1.59TCr | |
-1.08% | 1.4TCr | |
-11.15% | 1.17TCr | |
+169.04% | 1.02TCr | |
-50.19% | 1TCr |
- Stock Market
- Equities
- A304360 Stock
- Company S.Biomedics CO., LTD.